| Literature DB >> 12835671 |
John R W Masters1, Beate Köberle.
Abstract
Most metastatic cancers are fatal. More than 80% of patients with metastatic testicular germ-cell tumours (TGCTs), however, can be cured using cisplatin-based combination chemotherapy. Why are TGCTs more sensitive to chemotherapeutics than most other tumour types? Answers to this question could lead to new treatments for metastatic cancers.Entities:
Mesh：
Substances：
Year: 2003 PMID： 12835671 DOI： 10.1038/nrc1120
Source DB: PubMed Journal: Nat Rev Cancer ISSN： 1474-175X Impact factor: 60.716